Unlock stock picks and a broker-level newsfeed that powers Wall Street.

Copenhagen - Delayed Quote DKK

Zealand Pharma A/S (ZEAL.CO)

Compare
424.50
-20.50
(-4.61%)
At close: 4:59:44 PM GMT+2
Currency in DKK All numbers in thousands
Download
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Total Revenue
62,691
62,691
342,788
103,986
108,546
Cost of Revenue
7,874
7,874
19,174
--
10,970
Gross Profit
54,817
54,817
323,614
103,986
97,576
Operating Expense
1,323,888
1,323,888
900,831
920,585
879,720
Operating Income
-1,269,071
-1,269,071
-577,217
-816,599
-782,144
Net Non Operating Interest Income Expense
128,739
128,739
16,343
-48,681
-7,520
Other Income Expense
--
--
--
--
30,777
Pretax Income
-1,083,445
-1,083,445
-708,865
-972,041
-758,887
Tax Provision
-4,617
-4,617
-5,126
-6,431
-3,949
Net Income Common Stockholders
-1,078,828
-1,078,828
-703,739
-1,202,135
-1,018,149
Diluted NI Available to Com Stockholders
-1,078,828
-1,078,828
-703,739
-1,202,135
-1,018,149
Basic EPS
-16.72
-16.24
-12.44
-26.02
-23.75
Diluted EPS
-16.72
-16.24
-12.44
-26.02
-23.75
Basic Average Shares
63,343.10
66,434.27
56,588.59
46,200.15
42,869.40
Diluted Average Shares
63,343.10
66,434.27
56,588.59
46,200.15
42,869.40
Total Operating Income as Reported
-1,272,207
-1,272,207
-572,238
-837,153
-784,317
Total Expenses
1,331,762
1,331,762
920,005
920,585
890,690
Net Income from Continuing & Discontinued Operation
-1,078,828
-1,078,828
-703,739
-1,202,135
-1,018,149
Normalized Income
-1,117,261.52
-1,117,261.52
-566,455.96
-834,122.71
-749,220.91
Interest Income
169,639
169,639
45,324
6,542
44
Interest Expense
34,047
34,047
25,831
56,455
4,091
Net Interest Income
128,739
128,739
16,343
-48,681
-7,520
EBIT
-1,049,398
-1,049,398
-683,034
-915,586
-754,796
EBITDA
-1,023,551
-1,023,551
-657,948
-797,625
-711,850
Reconciled Cost of Revenue
7,874
7,874
19,174
--
10,970
Reconciled Depreciation
25,847
25,847
25,086
117,961
42,946
Net Income from Continuing Operation Net Minority Interest
-1,078,828
-1,078,828
-703,739
-965,610
-754,938
Total Unusual Items Excluding Goodwill
38,598
38,598
-138,283
-132,363
-5,747
Total Unusual Items
38,598
38,598
-138,283
-132,363
-5,747
Normalized EBITDA
-1,062,149
-1,062,149
-519,665
-665,262
-706,103
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
164.48
164.48
-999.96
-875.71
-29.91
12/31/2021 - 11/23/2010

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

GUBRA.CO Gubra A/S
356.00
-4.30%
 
GMAB.CO Genmab A/S
1,291.50
-0.12%
 
BAVA.CO Bavarian Nordic A/S
151.65
+0.43%
 
ALK-B.CO ALK-Abelló A/S
148.60
+1.36%
 
GMAB Genmab A/S
19.55
+0.21%
 
ASND Ascendis Pharma A/S
158.15
+2.75%
 
YMAB Y-mAbs Therapeutics, Inc.
4.5400
-15.14%
 
BVNRY Bavarian Nordic A/S
7.62
+1.87%
 
GPCR Structure Therapeutics Inc.
18.53
-1.96%
 
EXPRS2.ST ExpreS2ion Biotech Holding AB (publ)
19.40
-0.92%